129 related articles for article (PubMed ID: 36222747)
21. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
22. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.
Kaibori M; Ishizaki M; Matsui K; Kwon AH
J Surg Oncol; 2010 Oct; 102(5):462-8. PubMed ID: 20872949
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
[TBL] [Abstract][Full Text] [Related]
24. Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.
Rui S; Yan J; Zhang H; Wang Z; Zhou W
Medicine (Baltimore); 2017 Jul; 96(30):e7608. PubMed ID: 28746212
[TBL] [Abstract][Full Text] [Related]
25. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
[TBL] [Abstract][Full Text] [Related]
26. A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.
Qu Q; Lu M; Xu L; Zhang J; Liu M; Jiang J; Zhao X; Zhang X; Zhang T
Br J Radiol; 2023 Mar; 96(1144):20220739. PubMed ID: 36877238
[TBL] [Abstract][Full Text] [Related]
27. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
Li Q; Li H; Qin Y; Wang PP; Hao X
J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
[TBL] [Abstract][Full Text] [Related]
28. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study.
Li Z; Zhao X; Jiang P; Xiao S; Wu G; Chen K; Zhang X; Liu H; Han X; Wang S; Li X
Medicine (Baltimore); 2016 Aug; 95(31):e4224. PubMed ID: 27495026
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
Huang G; Lau WY; Zhou WP; Shen F; Pan ZY; Yuan SX; Wu MC
JAMA Surg; 2014 Jun; 149(6):519-27. PubMed ID: 24696192
[TBL] [Abstract][Full Text] [Related]
30. Microvascular invasion risk scores affect the estimation of early recurrence after resection in patients with hepatocellular carcinoma: a retrospective study.
Wang S; Zheng W; Zhang Z; Zhang GH; Huang DJ
BMC Med Imaging; 2022 Nov; 22(1):204. PubMed ID: 36419016
[TBL] [Abstract][Full Text] [Related]
31. A nomogram to predict microvascular invasion in early hepatocellular carcinoma.
Li H; Li T; Hu J; Liu J
J Cancer Res Ther; 2021 Jul; 17(3):652-657. PubMed ID: 34269295
[TBL] [Abstract][Full Text] [Related]
32. Can IVIM help predict HCC recurrence after hepatectomy?
Zhang Y; Kuang S; Shan Q; Rong D; Zhang Z; Yang H; Wu J; Chen J; He B; Deng Y; Roberts N; Shen J; Venkatesh SK; Wang J
Eur Radiol; 2019 Nov; 29(11):5791-5803. PubMed ID: 30972544
[TBL] [Abstract][Full Text] [Related]
33. Surgical management of hepatocellular carcinoma: resection or transplantation?
Philosophe B; Greig PD; Hemming AW; Cattral MS; Wanless I; Rasul I; Baxter N; Taylor BR; Langer B
J Gastrointest Surg; 1998; 2(1):21-7. PubMed ID: 9841964
[TBL] [Abstract][Full Text] [Related]
34. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.
Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF
J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.
Wang L; Jin YX; Ji YZ; Mu Y; Zhang SC; Pan SY
World J Gastroenterol; 2020 Apr; 26(14):1647-1659. PubMed ID: 32327913
[TBL] [Abstract][Full Text] [Related]
36. Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.
Mathews P; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Lyu H; Jaffee E; Zheng L; Yu E; Lee YJ
Ann Surg Oncol; 2013 Apr; 20(4):1216-22. PubMed ID: 23104706
[TBL] [Abstract][Full Text] [Related]
37. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
[TBL] [Abstract][Full Text] [Related]
39. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
[TBL] [Abstract][Full Text] [Related]
40. Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
Kong J; Liang X; Zhang J; Zeng J; Liu J; Zeng J
Dig Dis Sci; 2022 Aug; 67(8):4250-4257. PubMed ID: 34523084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
